Bayer AG Shareholders’ Equity Growth & History (BAYN)

Bayer AG's shareholders’ equity was €25.95B for fiscal 2025.

View full Bayer AG company overview

Bayer AG annual shareholders’ equity history

Bayer AG annual shareholders’ equity

Fiscal yearPeriod endedShareholders’ equityChangeGrowth
20252025-12-31€25.95B−€5.96B−18.68%
20242024-12-31€31.91B−€1.02B−3.09%
20232023-12-31€32.93B−€5.85B−15.08%
20222022-12-31€38.77B€5.75B+17.42%
20212021-12-31€33.02B€2.50B+8.18%
20202020-12-31€30.52B−€16.81B−35.52%
20192019-12-31€47.34B€1.36B+2.96%
20182018-12-31€45.98B€9.18B+24.93%
20172017-12-31€36.80B€6.47B+21.32%
20162016-12-31€30.33B€6.07B+25.01%
20152015-12-31€24.27B€4.16B+20.69%
20142014-12-31€20.11B−€612.0M−2.95%
20132013-12-31€20.72B€2.25B+12.18%
20122012-12-31€18.47B−€743.0M−3.87%
20112011-12-31€19.21B€379.0M+2.01%
20102010-12-31€18.83B

Bayer AG shareholders’ equity trends

Over the last five fiscal years, Bayer AG's shareholders’ equity decreased from €30.52B to €25.95B, a change of −€4.58B. The latest reported quarter, Q2 2026, shows €29.58B.

About the metric

What shareholders’ equity means

Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.

Calculation and source

reported shareholders’ equity

TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bayer AG source filings ↗

Community posts

It’s quiet here.

No posts about BAYN yet. Start the conversation.

Write the first post